## Abstract The PI3KโAKT pathway is activated in a variety of human cancers, resulting in disturbance of cell growth, proliferation and survival. Among the factors affecting the pathway, the __KโRas__ mutation and __PIK3CA__ mutation are the most common oncogenic alterations in colorectal cancer. W
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
โ Scribed by Jyh-Ming Liou; Ming-Shiang Wu; Chia-Tung Shun; Han-Mo Chiu; Mei-Jyh Chen; Chien-Chuan Chen; Hsiu-Po Wang; Jaw-Town Lin; Jin-Tung Liang
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 206 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Mutational analysis of __KRAS__ codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to antiโEGFR therapies. However, even among patients whose tumors are wildtype for __KRAS__ codons 12 and 13, only a subse
## Abstract The RASโMAPK, PI (3)K signaling pathways form a network that play a central role in tumorigenesis. The __BRAF__, __KRAS__ and __PI3KCA__ genes code 3 partners of this network and have been found to be activated by mutation in colorectal cancer; these mutations lead to unrestricted cell
## Abstract Mutations of the __KRAS__, __BRAF__, and __PIK3CA__ genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)โtargeted monoclonal antibody therapy. These reports have mainly emanated from Western countries, however, and li